Navigation Links
Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year
Date:2/13/2008

al studies, Mozobil showed the ability to quickly and predictably

prepare cancer patients for a transplant to treat their disease.

Genzyme plans to file mid year for U.S. and European approval for the

product's use in treating patients with multiple myeloma and patients

with lymphoma. The company plans to launch the product early next year

upon approval and to rapidly expand the product's availability around

the world. The company expects peak annual sales of the product in the

transplant setting of $400 million. Genzyme is also exploring

additional indications for Mozobil, including its near-term potential

use in chemosensitization procedures.

Clolar for adult AML

-- Clolar is approved in the United States and Europe for the treatment of

acute lymphoblastic leukemia in relapsed and refractory pediatric

patients. Genzyme is developing the product for use globally as a

first-line therapy for the treatment of adult acute myeloid leukemia

and myelodysplastic syndromes, significantly larger indications that

the company estimates will drive peak annual sales of the product to

approximately $600 million. The company intends to submit a

supplemental new drug application in the United States later this year

to include an adult AML indication, following the completion of its

CLASSIC II clinical trial involving older adult AML patients. The

company also expects to provide additional clinical data to European

authorities to supplement the regulatory submission filed previously by

Bioenvision.

Mipomersen for high-risk cardiovascular disease

-- Mipomersen is being developed primarily for patients at significant

cardiovascular risk who are unable to achieve target cholesterol levels

with statins alone or who are intolerant of statins. Mipomer
'/>"/>

SOURCE Genzyme Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine news :

1. Genzyme Receives FDA Response Letter on Synvisc-One(TM)
2. Bioenvision Shareholders Approve Acquisition by Genzyme Corporation
3. Genzyme Statement Regarding Results of FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
4. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
5. Delaware Court Approves Bioenvision, Genzyme Joint Petition
6. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
7. Liquent Insight Publisher 3.6 Delivers Advanced Submission Capabilities
8. March of Dimes Delivers a New Look
9. Independence Blue Cross Delivers Important Reminder to Women during Cervical Cancer Awareness Month
10. PARIs eFlow Delivers Alnylam RNAi Therapeutic in Phase I Study
11. Gleevec, the targeted cancer pill, delivers more good news to patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... Thompson HealthDay Reporter FRIDAY, ... previously given to two American aid workers successfully cured a ... tests, researchers report. The drug, ZMapp, prompted recovery in ... get the medication until five days after infection. ZMapp ... days or even hours away from death, said study senior ...
(Date:9/1/2014)... September 01, 2014 As well as ... Derek is currently pursuing counselor certification in Louisiana. ... through the CPI training program as well as the ... have grown both personally and professionally. I am ... am competently able to do so. As a ...
(Date:9/1/2014)... New York (PRWEB) September 01, 2014 ... store, retrieve, organize and analyze biological and genetic ... of the activity of developing software tools to ... not to be confused with biological computation. While ... better understanding of biology can its related concepts, ...
(Date:9/1/2014)... September 01, 2014 Registration is now open ... 5K and 1-Mile Race to be held on Sunday, September ... Court Yard at Harmon Meadow in Secaucus, New Jersey. All ... a national nonprofit dedicated to restoring a sense of self, ... members and our military families. , General registration is $30 ...
(Date:9/1/2014)... 2014 Daily Gossip reveals in it's ... community that gives members access to thousands of professionally ... online resource aims to help both people who plan ... who are looking for inspiration in creating one of ... Me Now by visiting the official website at: ...
Breaking Medicine News(10 mins):Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 2Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 3Health News:Narconon Louisiana Announces New Certifications For Staff 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2Health News:Tattoo Me Now Review Reveals Unique Ideas for Tattoo Designs 2
... Tampa, FL (May 28, 2008) -- The protein MAEBL ... parasites in mosquitoes, allowing the insects to transmit the ... Florida study has shown. The research may ultimately help ... development of the malaria parasite in the mosquito. , ...
... research, published in the May 28, 2008 edition of ... normalizes the action of certain brain cells altered by ... known as the central amygdala, which plays an important ... in regulating alcohol drinking. In the study, alcohol-dependent rodents ...
... Most Americans don,t believe,they could perform cardiopulmonary resuscitation ... save a life in a cardiac emergency,according to a ... survey of more than 1,100 adults, 89 percent said ... if they witnessed a medical,emergency. Yet only 21 percent ...
... networks and treatment choices can have a vital impact in helping ... patients start and stay ... percent) with,multiple sclerosis (MS) who have started treatment say their commitment ... for,staying on therapy, according to a new North American survey of ...
... of these procedures may just be matter of convenience , , ... babies in the United States have been on the rise ... sections account for nearly all of the increase. , "I ... been done on these two increasing problems," said Dr. Alan ...
... Plant Biologists (ASPB) and the Sociedad Mexicana De Bioquimica Rama: ... 2225, 2008 in the Fiesta Americana Hotel in Merida, Mexico. ... meeting is the biology and agriculture of plant species that ... on the international collaborations to study and improve these crops ...
Cached Medicine News:Health News:Protein plays key role in transmitting deadly malaria parasite 2Health News:Scripps Research scientists find seizure drug reverses cellular effects 2Health News:American Heart Association Survey Reveals Americans Lack Confidence in Lifesaving Skills for Common Cardiac Emergency 2Health News:American Heart Association Survey Reveals Americans Lack Confidence in Lifesaving Skills for Common Cardiac Emergency 3Health News:American Heart Association Survey Reveals Americans Lack Confidence in Lifesaving Skills for Common Cardiac Emergency 4Health News:American Heart Association Survey Reveals Americans Lack Confidence in Lifesaving Skills for Common Cardiac Emergency 5Health News:American Heart Association Survey Reveals Americans Lack Confidence in Lifesaving Skills for Common Cardiac Emergency 6Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 2Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 3Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 4Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 5Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 6Health News:C-Sections Explain Jump in U.S. Preemie Births 2Health News:C-Sections Explain Jump in U.S. Preemie Births 3Health News:ASPB engages Latin America colleagues at Annual Meeting in Merida, Mexico June 22-25 2Health News:ASPB engages Latin America colleagues at Annual Meeting in Merida, Mexico June 22-25 3
(Date:8/29/2014)... Calif. , Aug. 29, 2014 Thoratec ... in device-based mechanical circulatory support therapies to save, support ... participating in the 2014 Morgan Stanley Global Healthcare Conference ... Burbach , President and Chief Executive Officer, will provide ... Eastern Daylight Time (9:55 a.m., Pacific Daylight Time).   ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "China Orthopedic Instrument Industry Report, 2014-2017" report to ... population and rising proportion of reimbursement for medical expenses, ... released, with its scale presenting a CAGR of 19.2% ... are three product segments of orthopedic instruments in ...
(Date:8/29/2014)... Research and Markets  has announced the addition ... report to their offering. The Central ... the largest segments of pharmaceuticals industry. The numbers of CNS ... therapies were unable to meet the market requirements. There has ... disorder, especially over the past two decades. The market for ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2US CNS Disorders Drug Pipeline Insight 2014 2
... , , , ... , SILVER SPRING, Md., Sept. 11 The U.S. Food ... cancer in a pelvic mass that is already known to require surgery. ... type of surgery should be done and by whom. , , ...
... LISBON, Portugal, September 11 , ... of the New Intranasal Treatment,for Breakthrough Cancer Pain Over OTFC ... demonstrate the efficacy of Instanyl in,management of breakthrough cancer pain. ... European Federation of Chapters of the International,Association for the Study ...
Cached Medicine Technology:FDA Clears a Test for Ovarian Cancer 2Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 2Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 3Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 4
... Proven tension-free sling technology ... porcine acellular collagen matrix sling, ... tissue-to-tissue contact between sling and ... urethral or vaginal abrasion or ...
... Delivers the advanced performance ... exceptional strength, versatility, and durability ... implant that augments the effectiveness ... pelvic floor reconstruction. Comprised of ...
... system is a state-of-the-art, comprehensive cardiac ... programs, modalities, and parameters are highly ... multiple applications including cardiac and pulmonary ... clinics. Its open architecture delivers flexibility ...
NephroMax High Pressure Nephrostomy Balloon Catheter allows one-step, atraumatic dilatation of the nephrostomy tract....
Medicine Products: